1,000
Participants
Start Date
January 27, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Oral/Throat cancer test
The Oral/Throat cancer test is intended for the qualitative detection of molecular features (human genes, microbial species and functions) associated with Oral Squamous Cell Carcinoma (OSCC) or OroPharyngeal Squamous Cell Carcinoma (OPSCC) in saliva samples from adults with a suspicion of cancer. A positive result from CDOT may indicate the presence of OSCC or OPSCC. The device is intended as a diagnostic aid for clinicians when assessing patients with suspected OSCC or OPSCC who may benefit from follow-up diagnosis and treatment. The device is not intended for a definitive diagnosis.
RECRUITING
UTHSC, Memphis
RECRUITING
Missouri School of Dentistry & Oral Health, St Louis
Viome
INDUSTRY